This weekend, the Pan-Mass Challenge (PMC) unites more than 6,500 riders and 3,500 volunteers for its 46th ride, with the ...

Researchers have identified eIF2A as a key protein that guides melanoma cells during metastasis. Known for its role in aiding ...

A multi-institutional study found that 42% of ovarian cancer patients in clinical remission still harbored minimal residual ...

A novel radioimmunotherapy strategy has shown compelling efficacy in eliminating ovarian cancer stem cells in preclinical ...

The ARANOTE trial showed that adding darolutamide to ADT reduced the risk of progression or death by 46% in metastatic ...

The popular artificial sweetener sucralose may impair cancer immunotherapy by depleting arginine—an amino acid essential for ...

A global study demonstrated that CAR-T cell therapy is linked to significantly increased risks of secondary cancers—8.9-fold ...

Gnosis has announced the launch of EdenDx, the first non-invasive, liquid-based cytology test for early endometrial cancer ...

Eli Lilly’s first-in-class non-covalent BTK inhibitor, demonstrated superior overall response rates compared to Imbruvica in ...

Researchers have enhanced cisplatin’s efficacy in advanced NSCLC by transplanting functional mitochondria from cardiomyocytes ...

A new study published in Cancer Cell reveals that blocking a key nutrient-scavenging process in pancreatic tumors reprograms ...

Nuvisertib, an oral PIM1 kinase inhibitor from Sumitomo Pharma, has received Orphan Drug Designation from the EMA for ...